NN2211, a Novo Nordisk GLP-1 derivate, suppresses appetite in wild type but not in GLP-1R-/- mice

被引：0
|
作者：
Bjenning, CA [1 ]
Romer, J [1 ]
Knudsen, LB [1 ]
机构：
[1] Novo Nordisk AS, DK-2820 Gentofte, Denmark
来源：
OBESITY RESEARCH | 2001年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119S / 119S
页数：1
相关论文
共 50 条
  • [11] No impairment of hypoglycemia counterregulation via glucagon with NN2211, a GLP-1 derivative, in subjects with type 2-diabetes
    Nauck, M
    El-Ouaghlidi, A
    Hompesch, M
    Jacobson, J
    Elbroend, B
    DIABETES, 2003, 52 : A128 - A128
  • [12] The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice
    Rolin, B
    Larsen, MO
    Gotfredsen, CF
    Deacon, CF
    Carr, RD
    Wilken, M
    Knudsen, LB
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (04): : E745 - E752
  • [13] Sustained appetite suppression and weight loss in obese rhesus monkeys treated with a long-acting GLP-1 derivative, NN2211
    Hansen, BC
    Bjenning, C
    Knudsen, LB
    DIABETOLOGIA, 2001, 44 : A196 - A196
  • [14] The GLP-1 derivative NN2211 inhibits cytokine-induced apoptosis in primary rat β-cells
    Bregenholt, S
    Moldrup, A
    Knudsen, LB
    Petersen, JS
    DIABETES, 2001, 50 : A31 - A31
  • [15] NN2211, a long-acting derivative of GLP-1, lowers blood glucose in ob/ob and db/db mice
    Larsen, MO
    Rolin, B
    Wilken, M
    Carr, RD
    Knudsen, LB
    DIABETES, 2000, 49 : A1 - A1
  • [16] The GLP-1 derivative NN2211 restores β-cell sensitivity to glucose in type 2 diabetic patients after a single dose
    Chang, AM
    Jakobsen, G
    Sturis, J
    Smith, MJ
    Bloem, CJ
    An, B
    Galecki, A
    Halter, JB
    DIABETES, 2003, 52 (07) : 1786 - 1791
  • [17] Plasma protein binding of NN2211, a long-acting derivative of GLP-1, is important for its efficacy
    Knudsen, LB
    Knudsen, SM
    Wilken, M
    Colding-Joergensen, M
    Plum, A
    Ribel, U
    Agersoe, H
    Hansen, K
    DIABETES, 2003, 52 : A321 - A322
  • [18] The GLP-1 derivative NN2211 normalizes food intake and lowers body weight in a hyperphagic minipig model
    Raun, K
    Von Voss, P
    Ankersen, T
    Bollen, P
    Knudsen, LB
    DIABETES, 2003, 52 : A325 - A325
  • [19] Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R-/- mice
    Rafferty, Eamon P.
    Wylie, Alastair R.
    Hand, Katharine H.
    Elliott, Chris E.
    Grieve, David J.
    Green, Brian D.
    BIOLOGICAL CHEMISTRY, 2011, 392 (06) : 539 - 546
  • [20] NN2211, a long-acting GLP-1 derivative, decreases blood glucose and stimulates β-cell proliferation in db/db mice
    Larsen, MO
    Gotfredsen, CF
    Rolin, B
    Wilken, M
    Knudsen, LB
    DIABETOLOGIA, 2001, 44 : A197 - A197
12345